Societe Clear Skin Pads Liquid
FDA Label NDC 87700-147

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Societe Clinical Skincare for the product Societe Clear Skin Pads (NDC 87700-147). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient, otc - purpose, uses, warnings, otc - keep out of reach of children, directions, inactive ingredients, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Active Ingredient

Salicylic Acid 2.0%

Otc - Purpose

Acne Treatment

Uses

  • For the management of acne
  • Helps keep skin clear of new acne blemishes

Warnings

For external use only

When using this product

  • Skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.

Directions

  • Apply evenly over face, avoiding the eye are. Do not rinse. Allow face to dry before applying any additional products. Replace inner lid after each use. Tighten lid after use to prevent pads from drying out. Use daily in PM.

Inactive Ingredients

Water
Ethanol
Glycolic Acid
Dimethyl Isosorbide
Lactic Acid
Cocoyl Arginine Amide
Glycerin
Myristoyl Tetrapeptide-13
Lactobacillus/Saccharomyces/Rice/Sucrose Ferment Filtrate
L-Mandelic Acid
Citric Acid
Epilobium Fleischeri Extract
Syringa Vulgaris (Lilac) Extract
Citrus Paradisi (Grapefruit) Fruit Extract
Mirabilis Jalapa Extract
Menthol
Mentha Piperita (Peppermint) Oil
Citrus Grandis (Grapefruit) Peel Essential Oil
Butylene Glycol
Maltodextrin
Polyquaternium-10
1,2-Hexanediol
Propanediol
Potassium Hydroxide
Caprylyl Glycol

* Please review the disclaimer below.